Navigation Links
Neuralstem Updates NSI-189 Major Depression Trial
Date:6/20/2011

ROCKVILLE, Md., June 20, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been approved to dose the final cohort in the ongoing Phase Ia trial to test the safety of NSI-189 for the treatment of major depression. Phase Ia is testing the drug in healthy volunteers for safety and tolerability. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression and other diseases and conditions, such as Alzheimer's disease and post-traumatic stress disorder (PTSD).

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

"The trial is proceeding as expected," said Karl Johe, PhD, Chief Scientific Officer and Chairman of Neuralstem's Board of Directors. "There have been no adverse events to date. We are on schedule to complete Phase Ia in July, and with approval from the FDA, plan to begin Phase Ib this fall." Phase Ib will test the safety and tolerability of NSI-189 in patients with major depression.

About NSI-189

NSI-189 is the lead compound in Neuralstem's neurogenerative small molecule drug platform, which the company plans to develop into orally administered drugs for major  depression and other psychiatric disorders.

NSI-189 stimulated neurogenesis of human hippocampus-derived neural stem cells in-vitro. In mice, NSI-189 stimulated neurogenesis in the hippocampus and increased its volume. In humans, NSI-189 may reverse the human hippocampal atrophy seen in major depression and other disorders. This program has received significant support from both the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH).

About the Trial

This Phase Ia trial tests a single dose of NSI-189 in healthy patients. If the safety endpoints ar
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
2. Neuralstem Updates ALS Clinical Trial Progress
3. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
4. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
5. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
6. Neuralstems ALS Trial on Clinical Hold
7. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
8. Neuralstem Announces Issuance of Core Technology Patent in Europe
9. Research 2.0 Updates Coverage of Viral Genetics with Research Report Focused on VG Energy
10. Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs
11. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and the Indiana ... Forum to state legislators. The new policy forum was ... Indianapolis and featured two panel ... and State Sen. Brandt Hershman . Legislators also ... & Development Center, which is under construction on its ...
(Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, ... has acquired MACTek Corporation, a leading provider of ... Pepperl+Fuchs, strategy to further extend its integrated solutions ... market.    "We are pleased to ... existing portfolio," said Jim Bolin , Pepperl+Fuchs, ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... with HALO device leads to 100% patient response ... ... Calif., May 20 BARRX Medical, Inc., a global,technology leader in ... which report a 100% eradication,rate for early esophageal cancer and pre-cancerous ...
... Technologies,Inc. (Amex: PTN ) announced today that ... study of PL-3994, a novel, long-acting natriuretic peptide,receptor ... The study is placebo-controlled and double-blinded, and will ... many as 35 subjects will be,included, with six ...
Cached Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... ... been updated to include a wealth of information for specific translation services within ... great expertise and an incredible track record of successful work. , ITC Global ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, a ... ” tool, which summarizes all available plans, plan maximums, pre-existing condition coverage limits ... to help India Network members make an informed decision regarding the care they ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... classes. , Starting September 1st they are offering pre and postnatal ... and "Healthy Body, Healthy Baby." , More information can be found at 248-601-6683. ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Sundance Film Festival award winning documentary ... , “Alive Inside” shadows a social worker who advocates for the use of music ... about bringing music to residents in health care centers who may have lost a ...
(Date:8/31/2015)... ... August 31, 2015 , ... Since 1946, the doctors and ... From the moment a patient arrives at the office, the staff will make ... with each and every patient to create a complete dental treatment plan that is ...
Breaking Medicine News(10 mins):Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2
... , , MANHATTAN ... (SRC) held its first benefit, dessert and silent auction ... Founder, Jennifer Hoffiz, said, "The concert was well attended and the ... the silent auction allow SRC to offer 3 or 4 scholarships ...
... uses not approved by FDA , WEDNESDAY, Sept. 2 (HealthDay ... settlement in U.S. history, the Justice Department said Wednesday that ... pay a $2.3 billion penalty for illegally promoting certain drugs. ... painkillers called Cox-2 inhibitors, which Pfizer pulled from the market ...
... , , MINNEAPOLIS and ST. ... today announced the appointment of Molly Culligan to its board of ... out of promoting Minnesota to others, and she has dedicated herself ... to live. It is this sense of pride in her ...
... ... sun lamps and tanning beds, ultraviolet radiation is linked to skin cancers and to other ... Women,s Health Watch. , ... MA (Vocus) September 2, 2009 -- Whether it comes from the sun or from artificial ...
... Mass., Sept. 2 Hologic, Inc. (Nasdaq: HOLX ) ... the 2009 Morgan Stanley Global Healthcare Unplugged Conference in New York ... , , Interested parties are invited to listen ... investor section of the company,s website at www.hologic.com/investor ...
... , , DALLAS, Sept. 2 ... the leader in email encryption services, today announced that Humana renewed its ... Humana,s original agreement which has now spanned seven successful years. This ... to 36,000. , , Humana is a ...
Cached Medicine News:Health News:Sensory Research Center Benefit Concert Yields Scholarships for Autistic Children 2Health News:Pfizer to Pay Record Fine in Fraud Probe 2Health News:Children's Hospitals and Clinics of Minnesota Welcomes Twin Cities Businesswoman Molly Culligan to its Board of Directors 2Health News:Tanning Beds as Harmful as Tanning in the Sun, Reports Harvard Women's Health Watch 2Health News:Zix Corporation and Humana Renew and Expand Exclusive Agreement 2
... monitor elevates bedside glucose testing to a ... the quality of central laboratory testing. ... strip technology. Current glucose strips use ... system measures and corrects hematocrit interference as ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... BreatheX is a wearable CPAP (Continuous Positive ... sleep apnea. The lightweight BreatheX CPAP device ... with its built-in, rechargeable battery, and is ... no longer need to be "plugged in ...
Paraffin Block Storage System...
Medicine Products: